Enhance AI Data Protection: Organizations should adopt risk-proportional protection measures and invest in proactive data protection to benefit from potential incentives.

You’ll find easy-to-digest expert articles, in-depth whitepapers, and inspiring case studies that explore what’s next in regenerative medicine, microbial analysis, and biopharmaceutical production.

International experts from leading universities, global biopharmaceutical companies, and investment organizations will convene in Riyadh, Saudi Arabia, September 14–16, 2026, for the fourth edition of ...

CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted ...

From precision gene editing to real-time process monitoring, the collection showcases the technologies that are pushing the boundaries of what’s possible in biotech. Inside, you’ll find how advanced ...

More than a third of households in both Central Indiana and across the state are struggling to afford basic necessities — including housing, childcare, food, transportation, healthcare and technology, ...

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced ...

Anthropic launched Claude Fable 5 on June 9, calling it the most powerful AI model the company has made widely available. But the release comes with a catch: some of the model’s most sensitive ...

To protect against bioweapons, Anthropic told The Verge Fable’s ‘overly conservative’ safeguards block ‘most queries tied to biology work.’ To protect against bioweapons, Anthropic told The Verge ...